IDOV-Immune
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IDOV-Immune, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]